Oxford BioMedica PLC
LSE:OXB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Oxford BioMedica PLC
Oxford BioMedica PLC
Free Cash Flow
Oxford BioMedica PLC
Free Cash Flow Peer Comparison
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oxford BioMedica PLC
LSE:OXB
|
Free Cash Flow
-£38.3m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Free Cash Flow
-$160.5m
|
CAGR 3-Years
-147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Free Cash Flow
-$156.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Free Cash Flow
-$85.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Free Cash Flow
-£2.5m
|
CAGR 3-Years
66%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Free Cash Flow
£10m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-9%
|
See Also
What is Oxford BioMedica PLC's Free Cash Flow?
Free Cash Flow
-38.3m
GBP
Based on the financial report for Dec 31, 2023, Oxford BioMedica PLC's Free Cash Flow amounts to -38.3m GBP.
What is Oxford BioMedica PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-12%
Over the last year, the Free Cash Flow growth was -33%. The average annual Free Cash Flow growth rates for Oxford BioMedica PLC have been -55% over the past three years , and -12% over the past ten years .
You don't have any saved screeners yet
